Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tim O. who wrote (8015)	3/13/2003 2:52:08 PM
From: Biomaven	Read Replies (1) of 52153

I'm afraid I haven't looked at CEGE in a while. I made a decision quite a while back to generally avoid cancer vaccine projects, and I assume that is still what they are focused on. Right now the market doesn't want to pay for anything that isn't a late stage or approved product. Not clear to me if this will change any time soon. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next